Compare BY & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BY | STAA |
|---|---|---|
| Founded | 1914 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2017 | N/A |
| Metric | BY | STAA |
|---|---|---|
| Price | $29.21 | $25.58 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 8 |
| Target Price | ★ $33.67 | $22.50 |
| AVG Volume (30 Days) | 197.2K | ★ 762.7K |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.37% | N/A |
| EPS Growth | ★ 1.54 | N/A |
| EPS | ★ 2.80 | N/A |
| Revenue | ★ $400,663,000.00 | $230,591,000.00 |
| Revenue This Year | $19.26 | N/A |
| Revenue Next Year | $3.88 | $22.61 |
| P/E Ratio | $10.42 | ★ N/A |
| Revenue Growth | ★ 7.23 | N/A |
| 52 Week Low | $22.63 | $13.50 |
| 52 Week High | $32.05 | $30.81 |
| Indicator | BY | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 65.80 | 44.70 |
| Support Level | $27.82 | $25.55 |
| Resistance Level | $28.45 | $26.93 |
| Average True Range (ATR) | 0.55 | 0.92 |
| MACD | 0.21 | -0.06 |
| Stochastic Oscillator | 90.54 | 3.75 |
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.